New Medicines for Tropical Diseases in Pregnancy: Catch-22
Open Access
- 17 June 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 5 (6) , e133
- https://doi.org/10.1371/journal.pmed.0050133
Abstract
Nicholas White and colleagues discuss why it is so important to conduct clinical trials of malaria treatments in pregnancy.Keywords
This publication has 11 references indexed in Scilit:
- Antimalarial dosing regimens and drug resistanceTrends in Parasitology, 2008
- Market Failure and the Poverty of New Drugs in Maternal HealthPLoS Medicine, 2008
- Pharmacokinetics of Sulfadoxine‐Pyrimethamine in HIV‐Infected and Uninfected Pregnant Women in Western KenyaThe Journal of Infectious Diseases, 2007
- The safety of amodiaquine use in pregnant womenExpert Opinion on Drug Safety, 2007
- Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilanceThe Lancet Infectious Diseases, 2007
- Epidemiology and burden of malaria in pregnancyThe Lancet Infectious Diseases, 2007
- Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitroReproductive Toxicology, 2006
- Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trialThe Lancet, 2005
- A systematic overview of published antimalarial drug trials.Transactions of the Royal Society of Tropical Medicine and Hygiene, 2004
- Studies on the toxicity of qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.1982